We aim to:

• provide state-of-the-art NMR services for internationally competitive biomedical research in fields including structural biology, signal transduction, membrane trafficking, cancer mechanisms and metabolic profiling of human disease,

• develop and make available next generation NMR technologies including high-field magnets, cryogenic probes, fast methods and high throughput autosamplers in order to open new avenues of scientific investigation, and

• support the NMR needs of collaborative research groups and global initiatives focusing on UK and European priority areas including structural proteomics, biomarker identification and drug discovery.